Joakim Wijkstrom

Insider Reports History

Entity
Individual
Location
2200 Pennsylvania Ave Nw, Suite 300 E, Washington, Dc, DC
Signature
/s/ Joakim Wijkstrom
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joakim Wijkstrom:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vanda Pharmaceuticals Inc. SVP, Chief Marketing Officer Common Stock 130K $546K $4.21 Mar 5, 2024 Direct

Insider Reports Filed by Joakim Wijkstrom

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VNDA Vanda Pharmaceuticals Inc. Mar 4, 2024 2 -$71.9K 4 Mar 6, 2024 SVP, Chief Marketing Officer
VNDA Vanda Pharmaceuticals Inc. Feb 16, 2024 1 $0 4 Feb 21, 2024 SVP, Chief Marketing Officer
VNDA Vanda Pharmaceuticals Inc. Aug 21, 2023 1 -$21.7K 4 Aug 23, 2023 SVP, Chief Marketing Officer
VNDA Vanda Pharmaceuticals Inc. Mar 2, 2023 2 -$74.1K 4 Mar 6, 2023 SVP, Chief Marketing Officer
VNDA Vanda Pharmaceuticals Inc. Feb 16, 2023 2 $0 4 Feb 21, 2023 SVP, Chief Marketing Officer
VNDA Vanda Pharmaceuticals Inc. Aug 22, 2022 1 -$37K 4 Aug 23, 2022 SVP, Chief Marketing Officer
VNDA Vanda Pharmaceuticals Inc. Feb 28, 2022 3 -$78.1K 4 Mar 2, 2022 SVP, Chief Marketing Officer
VNDA Vanda Pharmaceuticals Inc. Aug 20, 2021 1 -$56.2K 4 Aug 23, 2021 SVP, Chief Marketing Officer